Comments: US HB4619 | 2019-2020 | 116th Congress

Bill Title: Pharmaceutical REPAI Act Pharmaceutical Rebates for Excessive Pricing Above Inflation Act

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Introduced) 2019-10-08 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. [HB4619 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2019 US Congress HB4619 at this time.

Social Comments on US HB4619

feedback